Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Market Overview:
The global Orthobiologics Marketwas valued at USD 4.21 billion in 2016 and is projected to reach USD 6.51billion by 2025, growing at a CAGR of 4.96% from 2017 to 2025.
With increasing of popularity of sports and athletics, injuries associated to it are also increasing. Also, with changes in lifestyle of working class of large economy countries, problems like obesity and spinal cord disorders are becoming more prevalent. Therefore the orthobiologics market is going through a positive trend in market value.
Sample Infographics:
Market Dynamics:
1. Market Drivers
1.1 Increasing number of accidents and sport injuries
1.2 Growingnumber of spinal diseases and disorders
1.3 Rising number of obese citizen due to major lifestyle changes
1.4 Increase in demand of Minimally invasive processes
2. Market Restraints
2.1 High cost of complete treatment
Market Segmentation:
1. Global Orthobiologics Market, by Application:
1.1 Osteoarthritis and Degenerative Arthritis
1.2 Spinal Fusion
1.3 Soft-Tissue Injuries
1.4 Fracture Recovery
1.5 Maxillofacial and Dental Applications
2. Global Orthobiologics Market, by Product:
2.1 Viscosupplementation Products
2.2 Demineralized Bone Matrices
2.3 Synthetic Orthobiologics
2.4 Bone Morphogenic Protein
2.5 Allografts
2.6 Plasma-Rich Protein
2.7 Bone Marrow Aspirate Concentrate
3. Global Orthobiologics Market, by End User:
3.1 Hospitals, Orthopedic Clinics, & Ambulatory Care Centers
3.2 Research & Academic Institutes
4. Global Orthobiologics Market, by Region:
4.1 North America (U.S., Canada, Mexico)
4.2 Europe (Germany, UK, France, Rest of Europe)
4.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
4.4 Latin America (Brazil, Argentina, Rest of Latin America)
4.5 Middle East & Africa
Competitive Landscape:
The major players in the market are as follows:
1. DepuySynthes (A Subsidiary of Johnson & Johnson)
2. Medtronic PLC.
3. Stryker Corporation
4. Zimmer Biomet Holdings, Inc.
5. Harvest Technologies Corporation (A Terumo Bct Company)
6. Globus Medical, Inc.
7. Orthofix International N.V.
8. RTI Surgical, Inc.
9. K2M Group Holdings, Inc.
10. Kuros Biosciences Ltd.
11. Bioventus LLC
12. Nuvasive, Inc.
13. Seaspine Holdings Corporation
14. Arthrex, Inc.
15. Xtant Medical Holdings, Inc.
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.
RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the Orthobiologics Marketwas performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.
To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.
Request Sample 
Request Discount 
Inquire Before Buy
